Crescita Therapeutics Inc. Stock Other OTC
Equities
CRRTF
CA2258471028
Pharmaceuticals
Sales 2022 | 23.52M 17.21M | Sales 2023 | 17.52M 12.82M | Capitalization | 9.79M 7.16M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | -1M -732K | EV / Sales 2022 | 0.29 x |
Net cash position 2022 | 6.7M 4.9M | Net cash position 2023 | 8.13M 5.95M | EV / Sales 2023 | 0.09 x |
P/E ratio 2022 |
16.5
x | P/E ratio 2023 |
-4.9
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.65% |
Managers | Title | Age | Since |
---|---|---|---|
Serge Verreault
CEO | Chief Executive Officer | - | - |
Jose DaRocha
DFI | Director of Finance/CFO | - | 17-08-31 |
Daniel Chicoine
CHM | Chairman | 70 | 16-02-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 16-02-29 | |
Daniel Chicoine
CHM | Chairman | 70 | 16-02-29 |
John London
BRD | Director/Board Member | - | 16-02-29 |
1st Jan change | Capi. | |
---|---|---|
+29.68% | 681B | |
+25.07% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+14.68% | 235B | |
+4.71% | 199B | |
-12.43% | 189B | |
-3.79% | 157B |